D-0802-2021 Class II Terminated

Recalled by Akorn, Inc. — Lake Forest, IL

FDA drug recall D-0802-2021 was initiated by Akorn, Inc. on Aug 13, 2021 and is designated Class II. Reason for recall: Failed impurities/degradation specification: Out of Specification for an unknown impurity observed in topical product. The recall status is terminated (terminated Aug 17, 2022). Affected quantity: 264 bottles; 48 bottles lot 372286 and 216 bottles lot 372289.

Recall details

Product Type
Drugs
Report Date
Sep 22, 2021
Initiation Date
Aug 13, 2021
Termination Date
Aug 17, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
264 bottles; 48 bottles lot 372286 and 216 bottles lot 372289

Product description

Betamethasone Dipropionate Lotion USP (Augmented), 0.05%, packaged in a) 30 mL bottle (NDC 61748-480-30), b) 60 mL bottle (NDC 61748-480-60), Rx only, Manufactured by: Hi-Tech Pharmacal Co. Inc., Amityville,NY 11701

Reason for recall

Failed impurities/degradation specification: Out of Specification for an unknown impurity observed in topical product.

Distribution pattern

USA Nationwide

Code information

Lot #: a) 372286, 372289, Exp 1/31/2022, b) 372286, 372289, Exp 1/31/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0802-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0802-2021. Report a data issue: hello@regdatalab.com.